118 results on '"Tomida, Ryotaro"'
Search Results
2. Prognostication in Lymph Node-Positive Prostate Cancer with No PSA Persistence After Radical Prostatectomy
3. PSA doubling time 4.65 months as an optimal cut-off of Japanese nonmetastatic castration-resistant prostate cancer
4. Robot-assisted partial nephrectomy in younger versus older adults with renal cell carcinoma: a propensity score-matched analysis
5. Impact of lymph node dissection on surgical and oncological outcomes in patients undergoing robot-assisted radical cystectomy for bladder cancer: a multicenter retrospective study
6. Treatment patterns and prognosis in patients with Bacillus Calmette–Guérin-exposed high-risk non-muscle invasive bladder cancer: a real-world data analysis
7. Insulin receptor expression to predict resistance to axitinib and elucidation of the underlying molecular mechanism in metastatic renal cell carcinoma
8. Comparison of Cabozantinib and Axitinib as Second-line Therapy After Nivolumab Plus Ipilimumab in Patients With Metastatic Clear Cell Renal Cell Carcinoma: A Comparative Analysis of Retrospective Real-world Data
9. Robot‐assisted intracorporeal ileal conduit urinary diversion: A two‐center comparative study of Bricker versus Wallace ureteroileal anastomosis
10. Impact of carcinoma in situ on the outcome of intravesical Bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancer: a comparative analysis of large real-world data
11. A propensity score matching study on robot-assisted radical cystectomy for older patients: comparison of intracorporeal ileal conduit and cutaneous ureterostomy
12. Radical prostatectomy using the Hinotori robot‐assisted surgical system: Docking‐free design may contribute to reduction in postoperative pain.
13. Prognostic outcomes in patients with metastatic renal cell carcinoma receiving second‐line treatment with tyrosine kinase inhibitor following first‐line immune‐oncology combination therapy.
14. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy
15. The importance of laparoscopic surgery for young urologists remains unwavering even in the era of robot‐assisted surgery
16. The impact of second transurethral resection on survival outcomes in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette–Guérin therapy.
17. Real-world prostate-specific antigen response and progression to castration-resistant prostate cancer among men with metastatic castration-sensitive prostate cancer treated with apalutamide: a multi-institutional study in the Chu-shikoku Japan Urological Consortium
18. The importance of laparoscopic surgery for young urologists remains unwavering even in the era of robot‐assisted surgery.
19. Effect of Positive Biopsy Core Rate on Low-dose-rate Brachytherapy Outcomes in Intermediate-risk Prostate Cancer
20. Lymph node dissection during radical cystectomy for bladder cancer: A two‐center comparative study of robotic versus open surgery
21. Efficacy of fresh-frozen cadaveric surgical training for arteriovenous fistula in vascular access
22. Assistent guide: A novel device for ureteral stent placement in robot‐assisted intracorporeal ileal conduit
23. Impact of early urinary catheter removal on successful voiding and physical function in stroke patients
24. Prostate-specific Antigen Levels Following Brachytherapy Impact Late Biochemical Recurrence in Japanese Patients With Localized Prostate Cancer
25. Immune‐related adverse events in urothelial cancer patients: Adjustment for immortal time bias
26. Validation of the STAR-CAP clinical prognostic system for predicting biochemical recurrence after radical prostatectomy in a Japanese cohort.
27. PROSTATE-SPECIFIC ANTIGEN LEVEL AT 6 MONTHS AFTER RADICAL PROSTATECTOMY ENABLES STRATIFICATION OF FOLLOW-UP PERIODS IN THE CANCER REGIONAL ALLIANCES CRITICAL PATH
28. Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy
29. MO24-1 Comparison of Nivo-Ipi versus TKIs as first line therapy for mRCC: Real-world data from multicenter retrospective study
30. Efficacy and safety of second-line axitinib in octogenarians with metastatic renal cell carcinoma
31. Additional file 3 of Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study
32. Additional file 5 of Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study
33. Additional file 1 of Non-maintenance intravesical Bacillus Calmette–Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study
34. Radiotherapy plus androgen deprivation therapy for prostate‐specific antigen persistence in lymph node–positive prostate cancer.
35. Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study
36. Pembrolizumab for treating advanced urothelial carcinoma in patients with impaired performance status: Analysis of a Japanese nationwide cohort
37. PATIENT-REPORTED OUTCOME AFTER ILEAL NEOBLADDER
38. Prognostication in Japanese patients with bacillus Calmette‐Guérin‐unresponsive non‐muscle‐invasive bladder cancer undergoing early radical cystectomy.
39. Impact of the objective response to and number of cycles of platinum‐based first‐line chemotherapy for metastatic urothelial carcinoma on overall survival of patients treated with pembrolizumab.
40. Novel metastatic burden‐stratified risk model in de novo metastatic hormone‐sensitive prostate cancer.
41. Differential prognostic factors in low‐ and high‐burden de novo metastatic hormone‐sensitive prostate cancer patients.
42. Patient-reported outcomes after open radical prostatectomy, laparoscopic radical prostatectomy and permanent prostate brachytherapy
43. Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer.
44. Efficacy of fresh-frozen cadaveric surgical training for arteriovenous fistula in vascular access
45. FACTORS AFFECTING SHORT-TERM RENAL FUNCTION AFTER PARTIAL NEPHRECTOMY
46. MP97-03 APPLICATION OF LOCAL 18F-FLUORO-2-DEOXYGLUCOSE UPTAKE BY THE PROSTATE TO ASSESS PERIOPERATIVE RESULTS OF ROBOT-ASSISTED LAPAROSCOPIC RADICAL PROSTATECTOMY.
47. Retroperitoneal cutaneous ureterostomy following radical cystectomy: A multicenter comparative study of robotic versus open surgery.
48. Impact of health-related quality of life on repeat protocol biopsy compliance on active surveillance for favorable prostate cancer: results from a prospective cohort in the PRIAS-JAPAN study.
49. [PROSTATE-SPECIFIC ANTIGEN LEVEL AT 6 MONTHS AFTER RADICAL PROSTATECTOMY ENABLES STRATIFICATION OF FOLLOW-UP PERIODS IN THE CANCER REGIONAL ALLIANCES CRITICAL PATH].
50. Non-maintenance intravesical Bacillus Calmette-Guérin induction therapy with eight doses in patients with high- or highest-risk non-muscle invasive bladder cancer: a retrospective non-randomized comparative study.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.